US Hemostats Market Size study, by Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others) by Formulation (Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats, Others) by Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others) Forecasts 2022-2032
US Hemostats Market is valued approximately USD 620 million in 2023 and is anticipated to grow with a healthy growth rate of more than 9.46% over the forecast period 2024-2032. Hemostats serve as essential surgical instruments, specifically engineered to manage bleeding by either clamping blood vessels or tissue. These tools are meticulously crafted to temporarily halt the flow of blood or bodily fluids during surgical procedures or medical interventions. Available in a variety of configurations, hemostats commonly feature hinged, scissor-like handles equipped with locking mechanisms and serrated jaws to ensure a secure grip and precise control. Additionally, the key trend of US Hemostats Market is rising incidence of chronic diseases and trauma cases that anticipated to support the market growth. The prevalence of chronic diseases such as cardiovascular disorders, cancer, and liver diseases, along with the incidence of traumatic injuries, continues to rise in the United States. This has led to a higher demand for hemostatic products in various surgical interventions, emergency care, and trauma management.
Moreover, with advancements in medical technology and an aging population, the number of surgical procedures being performed is increasing. Hemostats are essential in controlling bleeding during surgeries, leading to a higher demand for these products. Also, minimally invasive surgical techniques are becoming more popular due to their benefits such as shorter recovery times and reduced complications. Hemostats play a crucial role in these procedures by facilitating faster hemostasis without the need for extensive suturing. Additionally, other factors support the market growth are expansion of healthcare facilities, and rising incidence of chronic diseases. However, allergic responses related to hemostats are expected to impede Hemostats Market growth during 2024 to 2032.
Major market player included in this report are:
Pfizer Inc.
Baxter International Inc.
Artivion, Inc.
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Type
Thrombin Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
By Formulation
Matrix and Gel Hemostats
Sheet and Pad Hemostats
Sponge Hemostats
Powder Hemostats
Others
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Others
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
Moreover, with advancements in medical technology and an aging population, the number of surgical procedures being performed is increasing. Hemostats are essential in controlling bleeding during surgeries, leading to a higher demand for these products. Also, minimally invasive surgical techniques are becoming more popular due to their benefits such as shorter recovery times and reduced complications. Hemostats play a crucial role in these procedures by facilitating faster hemostasis without the need for extensive suturing. Additionally, other factors support the market growth are expansion of healthcare facilities, and rising incidence of chronic diseases. However, allergic responses related to hemostats are expected to impede Hemostats Market growth during 2024 to 2032.
Major market player included in this report are:
Pfizer Inc.
Baxter International Inc.
Artivion, Inc.
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Type
Thrombin Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
By Formulation
Matrix and Gel Hemostats
Sheet and Pad Hemostats
Sponge Hemostats
Powder Hemostats
Others
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Others
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
CHAPTER 1. US HEMOSTATS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Hemostats Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Type
2.2.2. By Formulation
2.2.3. By Application
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US HEMOSTATS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US HEMOSTATS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US HEMOSTATS MARKET SIZE & FORECASTS BY TYPE 2022-2032
5.1. Thrombin Based Hemostats
5.2. Oxidized Regenerated Cellulose Based Hemostats
5.3. Combination Hemostats
5.4. Gelatin Based Hemostats
5.5. Collagen Based Hemostats
5.6. Others
CHAPTER 6. US HEMOSTATS MARKET SIZE & FORECASTS BY FORMULATION 2022-2032
6.1. Matrix and Gel Hemostats
6.2. Sheet and Pad Hemostats
6.3. Sponge Hemostats
6.4. Powder Hemostats
6.5. Others
CHAPTER 7. US HEMOSTATS MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
7.1. Orthopedic Surgery
7.2. General Surgery
7.3. Neurological Surgery
7.4. Cardiovascular Surgery
7.5. Reconstructive Surgery
7.6. Gynecological Surgery
7.7. Others
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Pfizer Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Baxter International Inc.
8.3.3. Artivion, Inc.
8.3.4. Company
8.3.5. Company
8.3.6. Company
8.3.7. Company
8.3.8. Company
8.3.9. Company
8.3.10. Company
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Hemostats Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Type
2.2.2. By Formulation
2.2.3. By Application
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US HEMOSTATS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US HEMOSTATS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US HEMOSTATS MARKET SIZE & FORECASTS BY TYPE 2022-2032
5.1. Thrombin Based Hemostats
5.2. Oxidized Regenerated Cellulose Based Hemostats
5.3. Combination Hemostats
5.4. Gelatin Based Hemostats
5.5. Collagen Based Hemostats
5.6. Others
CHAPTER 6. US HEMOSTATS MARKET SIZE & FORECASTS BY FORMULATION 2022-2032
6.1. Matrix and Gel Hemostats
6.2. Sheet and Pad Hemostats
6.3. Sponge Hemostats
6.4. Powder Hemostats
6.5. Others
CHAPTER 7. US HEMOSTATS MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
7.1. Orthopedic Surgery
7.2. General Surgery
7.3. Neurological Surgery
7.4. Cardiovascular Surgery
7.5. Reconstructive Surgery
7.6. Gynecological Surgery
7.7. Others
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Pfizer Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Baxter International Inc.
8.3.3. Artivion, Inc.
8.3.4. Company
8.3.5. Company
8.3.6. Company
8.3.7. Company
8.3.8. Company
8.3.9. Company
8.3.10. Company
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
LIST OF TABLES
TABLE 1. US Hemostats market, report scope
TABLE 2. US Hemostats market estimates & forecasts by Type 2022-2032 (USD Million)
TABLE 3. US Hemostats market estimates & forecasts by Formulation 2022-2032 (USD Million)
TABLE 4. US Hemostats market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 5. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. Hemostats market estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. U.S. Hemostats market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. U.S. Hemostats market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. List of secondary sources, used in the study of US Hemostats Market.
TABLE 14. List of primary sources, used in the study of US Hemostats Market.
TABLE 15. Years considered for the study.
TABLE 16. Exchange rates considered.
TABLE 1. US Hemostats market, report scope
TABLE 2. US Hemostats market estimates & forecasts by Type 2022-2032 (USD Million)
TABLE 3. US Hemostats market estimates & forecasts by Formulation 2022-2032 (USD Million)
TABLE 4. US Hemostats market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 5. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. US Hemostats market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. Hemostats market estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. U.S. Hemostats market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. U.S. Hemostats market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. List of secondary sources, used in the study of US Hemostats Market.
TABLE 14. List of primary sources, used in the study of US Hemostats Market.
TABLE 15. Years considered for the study.
TABLE 16. Exchange rates considered.
LIST OF FIGURES
FIG 1. US Hemostats market, research methodology
FIG 2. US Hemostats market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Hemostats market, key trends 2023
FIG 5. US Hemostats market, growth prospects 2022-2032
FIG 6. US Hemostats market, porters 5 force model
FIG 7. US Hemostats market, pestel analysis
FIG 8. US Hemostats market, value chain analysis
FIG 9. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 10. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 11. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 12. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 13. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 14. US Hemostats market, company market share analysis (2023)
FIG 1. US Hemostats market, research methodology
FIG 2. US Hemostats market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Hemostats market, key trends 2023
FIG 5. US Hemostats market, growth prospects 2022-2032
FIG 6. US Hemostats market, porters 5 force model
FIG 7. US Hemostats market, pestel analysis
FIG 8. US Hemostats market, value chain analysis
FIG 9. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 10. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 11. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 12. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 13. US Hemostats market by segment, 2022 & 2032 (USD Million)
FIG 14. US Hemostats market, company market share analysis (2023)
